Whitehawk Therapeutics (WHWK) Inventory Average (2022 - 2024)

Whitehawk Therapeutics (WHWK) has reported Inventory Average for 3 consecutive years, with $5.4 million the latest figure, recorded in Q4 2024.

• In Q4 2024, Inventory Average rose 7.34% year-over-year to $5.4 million; the TTM figure through Dec 2024 stood at $5.4 million (up 7.34% YoY), while the FY2024 annual figure was $5.9 million, up 41.63% from the prior year.
• Inventory Average eased to $5.4 million in Q4 2024 per WHWK's latest filing, from $5.8 million in the prior quarter.
• Across five years, Inventory Average topped out at $6.2 million in Q1 2024 and bottomed at $464500.0 in Q2 2022.
• Historically, Inventory Average has averaged $3.7 million across 3 years, with a median of $3.6 million in 2023.
• Annual changes were most pronounced in 2023 — Inventory Average jumped 681.49% — and 2024, when it gained 7.34%.
• Whitehawk Therapeutics' Inventory Average stood at $1.3 million in 2022, then surged by 286.97% to $5.0 million in 2023, then grew by 7.34% to $5.4 million in 2024.
• Business Quant data shows WHWK's Inventory Average at $5.4 million in Q4 2024, $5.8 million in Q3 2024, and $6.0 million in Q2 2024.